Literature DB >> 29774755

Radiographic progression in non-radiographic axial spondyloarthritis.

Mikhail Protopopov1, Denis Poddubnyy1,2.   

Abstract

INTRODUCTION: Non-radiographic axial spondyloarthritis (nr-axSpA) represents a subtype of axial spondyloarthritis (axSpA) with no significant structural damage in sacroiliac joints and spine. In addition, patients with nr-axSpA demonstrate a substantial burden of illness, and a considerable share of them might progress to radiographic axSpA (r-axSpA) over time. The amount and quality of published data allows crude estimation of progression rate and factors related to a higher risk of progression. Areas covered: This review discusses the available data reporting the rates and predictors of radiographic progression in the sacroiliac joints and in the spine in patients with nr-axSpA as well as predisposing factors for such a progression. Expert commentary: Most of the studies report about 10-40% of patients with nr-axSpA to progress to r-axSpA over a period of 2-10 years. Multiple risk factors for the radiographic sacroiliitis progression are outlined and explored. There are not enough data to presume that any treatment modality may influence progression from nr-axSpA to r-axSpA, with TNFi showing some promising results. Radiographic progression in the spine is in general low in nr-axSpA; thus, long-term studies are required to investigate the natural course of the progression and possible treatment effects.

Entities:  

Keywords:  Axial spondyloarthritis; ankylosing spondylitis; non-radiographic axial spondyloarthritis; progression; radiographic axial spondyloarthritis; radiographic progression

Mesh:

Year:  2018        PMID: 29774755     DOI: 10.1080/1744666X.2018.1477591

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  15 in total

Review 1.  Understanding the paradigm of non-radiographic axial spondyloarthritis.

Authors:  Diego Benavent; Victoria Navarro-Compán
Journal:  Clin Rheumatol       Date:  2020-09-29       Impact factor: 2.980

Review 2.  Nonradiographic axial spondyloarthritis: expanding the spectrum of an old disease: A narrative review.

Authors:  Marina Magrey; Sergio Schwartzman; Natasha de Peyrecave; Victor S Sloan; Jeffrey L Stark
Journal:  Medicine (Baltimore)       Date:  2022-04-15       Impact factor: 1.817

Review 3.  Educational needs and challenges in axial spondyloarthritis.

Authors:  Anand Kumthekar; Mohamad Bittar; Maureen Dubreuil
Journal:  Curr Opin Rheumatol       Date:  2021-07-01       Impact factor: 4.941

4.  No radiographic sacroiliitis progression was observed in patients with early spondyloarthritis at 6 years: results of the Esperanza multicentric prospective cohort.

Authors:  Cristina Fernández-Carballido; Carolina Tornero; M Carmen Castro-Villegas; Eva Galindez; José Francisco García-Llorente; María Luz García-Vivar; Beatriz Joven-Ibáñez; Xavier Juanola; Claudia Urrego-Laurín; Clementina López-Medina; Raquel Almodovar; Nieves Martínez-Alberola; Teresa Ruiz-Jimeno; Eugenio de Miguel
Journal:  RMD Open       Date:  2020-09

5.  Content validity of the ASQoL for use in a non-radiographic axial spondyloarthritis population: a qualitative study.

Authors:  Mark C Hwang; Mona Martin; Kristina Harris; Philip Geerdts; Jeffrey L Stark; John Reveille
Journal:  Qual Life Res       Date:  2020-07-01       Impact factor: 4.147

Review 6.  Promising Treatment Options for Axial Spondyloarthritis: An Overview of Experimental Pharmacological Agents.

Authors:  Hasan Tahir; Swetha Byravan; Armin Fardanesh; Arumugam Moorthy
Journal:  J Exp Pharmacol       Date:  2021-07-02

7.  Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort.

Authors:  Monika Hebeisen; Raphael Micheroli; Almut Scherer; Xenofon Baraliakos; Manouk de Hooge; Désirée van der Heijde; Robert Landewé; Kristina Bürki; Michael J Nissen; Burkhard Möller; Pascal Zufferey; Pascale Exer; Adrian Ciurea
Journal:  PLoS One       Date:  2020-03-20       Impact factor: 3.240

8.  Non-radiographic versus radiographic axSpA: what's in a name?

Authors:  Xabier Michelena; Clementina López-Medina; Helena Marzo-Ortega
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

9.  Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study.

Authors:  Karin Bengtsson; Helena Forsblad-d'Elia; Anna Deminger; Eva Klingberg; Mats Dehlin; Sofia Exarchou; Ulf Lindström; Johan Askling; Lennart T H Jacobsson
Journal:  Rheumatology (Oxford)       Date:  2021-06-18       Impact factor: 7.580

10.  Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study.

Authors:  Atul Deodhar; Ricardo Blanco; Eva Dokoupilová; Stephen Hall; Hideto Kameda; Alan J Kivitz; Denis Poddubnyy; Marleen van de Sande; Anna S Wiksten; Brian O Porter; Hanno B Richards; Sibylle Haemmerle; Jürgen Braun
Journal:  Arthritis Rheumatol       Date:  2020-11-24       Impact factor: 15.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.